1. Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study. Issue 12 (December 2016) Authors: Pujol, Jean‐Louis; De Pas, Tommaso; Rittmeyer, Achim; Vallières, Eric; Kubisa, Bartosz; Levchenko, Eugeny; Wiesemann, Sebastian; Masters, Gregory A.; Shen, Robert; Tjulandin, Sergei A.; Hofmann, Hans‐Stefan; Vanhoutte, Nicolas; Salaun, Bruno; Debois, Muriel; Jarnjak, Silvija; De Sousa Alves, Pedr... Journal: Journal of thoracic oncology Issue: Volume 11:Issue 12(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗